Navigation Links
Complete Genomics Announces Its First Public Presentation at the 7th Annual BIO Investor Forum
Date:10/22/2008

MOUNTAIN VIEW, Calif., Oct. 22 /PRNewswire/ -- Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, today announced the company's presentation at the 7th Annual BIO Investor Forum, which will be held in San Francisco, Oct. 29-31, 2008.

Dr. Clifford Reid, chairman, president and chief executive officer of Complete Genomics, will present on Wednesday, Oct. 29, at 2:45 p.m. in the Marina Room of the Palace Hotel, located at 2 New Montgomery Street in downtown San Francisco. He will discuss how Complete Genomics' scalable service model and proprietary technology advances will allow the company to introduce its sequencing service in Q2 2009 at a cost of $5,000 per genome.

About Complete Genomics

Founded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. The company is currently building the world's largest human genome sequencing center. This development will allow pharmaceutical and biotechnology customers, for the first time, to conduct large-scale human genome studies that will help identify the genetic underpinnings of complex diseases and drug responses. For additional information about the company, please visit http://www.completegenomics.com.


'/>"/>
SOURCE Complete Genomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. American Oriental Bioengineering Completes Two Acquisitions
2. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
3. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
4. S*BIO Completes US$26 Million Equity Financing
5. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
6. CeNeRx BioPharma Completes $15 Million Series B Financing
7. eRT Completes Milestone 100th Thorough QT Study
8. Neptune Technologies successfully completes $2.75 million private placement with 10% management participation
9. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
10. Facet Solutions Completes Facet Joint and Disc Replacement Study
11. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Cynvenio Biosystems, Inc. a leader ... neoadjuvant breast cancer monitoring (NEAT) study in partnership with Allentown, PA-based TME Research ... patients to be monitored over two years with Cynvenio’s ClearID Breast Cancer blood test. ...
(Date:4/27/2017)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) today announced that its ... $250 million of the company,s common stock. This program ... December 31, 2017. Purchases may be made in the ... transactions from time to time as determined by United ...
(Date:4/27/2017)... ... April 27, 2017 , ... Mitotech S.A, a Luxembourg based ... Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic disease that leads to ... drops in a group of 20 patients carrying 11778, 14484 and 3460 mutations and ...
(Date:4/27/2017)... ... 27, 2017 , ... During the course of this webinar, ... 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn the medical indications and ... Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, will be the speaker ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):